According to Inozyme Pharma's latest financial reports the company's current earnings (TTM) are -C$0.11 B. In 2023 the company made an earning of -C$88.12 M an increase over its 2022 earnings that were of -C$93.16 M.The earnings displayed on this page is the company's Pretax Income.